No abstract available
Keywords:
ROS1; Thrombosis; Venous thromboembolic event.
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / genetics
-
Adenocarcinoma / pathology
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Biomarkers, Tumor / genetics
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / genetics
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Factor V / genetics*
-
Female
-
Gene Rearrangement*
-
Humans
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Male
-
Middle Aged
-
Prognosis
-
Protein-Tyrosine Kinases / genetics*
-
Proto-Oncogene Proteins / genetics*
-
Recurrence
-
Venous Thrombosis / chemically induced
-
Venous Thrombosis / genetics
-
Venous Thrombosis / pathology*
Substances
-
Biomarkers, Tumor
-
Proto-Oncogene Proteins
-
factor V Leiden
-
Factor V
-
Protein-Tyrosine Kinases
-
ROS1 protein, human